The company's products are mainly used in the fields of medicine, dietary supplements, cosmetics, etc., and have remarkable effects in anti-oxidation, delaying aging, and relieving diabetic neuropathy. The products are mainly exported, and have been exported to foreign markets such as Europe, America, Southeast Asia, etc., and the domestic market share of lipoic acid raw materials is among the highest, and long-term strategic cooperative relationships have been established with important domestic and foreign customers. The company focuses on R&D, production and sales of pharmaceutical intermediates, APIs and raw materials for health products. The main products include three series of products, including lipoic acid series, phosphatidylcholine series, and carnosine series. The main products include the lipoic acid series, phosphatidylcholine series, carnosine series, and imrecoxib raw materials. Company honors: Production Safety Standardization Certificate, Jiangsu Science and Technology Little Giant Enterprise, Food Business License, High-tech Enterprise, People's Republic of China Pharmaceutical Production License, Environmental Management System Certification Certificate, High-tech Enterprise, Changshu City Excellent Group Caring for the Next Generation of Jobs, etc.